医学アーカイブ

  • ISSN: 1989-5216
  • ジャーナル h-index: 22
  • 雑誌引用スコア: 4.96
  • ジャーナルのインパクトファクター: 4.44
インデックス付き
  • Genamics JournalSeek
  • 中国国家知識基盤 (CNKI)
  • 研究ジャーナル索引作成ディレクトリ (DRJI)
  • OCLC-WorldCat
  • プロクエスト召喚
  • パブロン
  • ジュネーブ医学教育研究財団
  • ユーロパブ
  • Google スカラー
  • 秘密検索エンジン研究所
このページをシェアする

抽象的な

A short diastolic dysfunction in hypertension treatment

Parash Gurram*

Changes in LV diastolic filling characterise Left Ventricular (LV) Diastolic Dysfunction (LVDD), which is a powerful predictor of cardiovascular events and heart failure. Hypertension is the most common cause of LVDD in the general population, and it promotes it through a variety of mechanisms, including hemodynamic overload and myocardial ischemia. Age, ethnicity, dietary sodium, obesity, diabetes mellitus, and chronic renal disease are all factors that contribute to LVDD in hypertensive people. LVDD can be improved by lowering blood pressure with antihypertensive drugs; however, it is uncertain if this improvement in LV diastolic function can improve cardio vasculature. Changes in LV diastolic filling characterise Left Ventricular (LV) Diastolic Dysfunction (LVDD), which is a powerful predictor of cardiovascular events and heart failure. Hypertension is the most common cause of LVDD in the general population, and it promotes it through a variety of mechanisms, including hemodynamic excess and myocardial infarction (Age, ethnicity, dietary sodium, obesity, diabetes mellitus, and chronic renal disease are all factors that contribute to LVDD in hypertension people. LVDD can be improved by lowering blood pressure with antihypertensive drugs; however, it is uncertain if this improvement in LV diastolic function can improve cardio vasculature. One of the early cardiac symptoms of systemic hypertension is abnormalities in left ventricular (LV) diastolic function in the presence of normal LV systolic performance.